Giussani D A, Jenkins S L, Mecenas C A, Winter J A, Honnebier B O, Wu W, Nathanielsz P W
Laboratory for Pregnancy and Newborn Research, Department of Physiology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401, USA.
Am J Obstet Gynecol. 1996 Mar;174(3):1050-5. doi: 10.1016/s0002-9378(96)70349-6.
Our purpose was to investigate the temporal relationship between delta4-androstenedione-induced preterm switching of myometrial activity patterns from contractures to contractions and maternal plasma estradiol and oxytocin concentrations in the 0.8 gestation rhesus monkey.
Eight rhesus monkeys (132 to 136 days' gestation) were instrumented under halothane with femoral artery and vein catheters and uterine electromyogram electrodes. At 138 to 142 days' gestation baseline maternal femoral artery blood samples for estradiol and oxytocin measurement were taken at 30-minute intervals for 7 hours, starting 2 hours before the onset of darkness. The day after baseline sampling a continuous intravenous delta4-androstenedione infusion (0.3 mg . kg-1 .hr-1 in 10% intralipid at 0.25 ml . hr-1) was started in four monkeys, while four monkeys were infused intravenously with intralipid alone. The sampling regimen was then repeated at 1 and 3 days after the start of the delta4-androstenedione or intralipid infusion. Contractions were counted and estradiol and oxytocin were measured by radioimmunoassay.
Androstenedione promoted a premature nocturnal increase in myometrial contractions in conjunction with an increase in maternal plasma concentrations of estradiol and oxytocin, which were of similar magnitude to those measured in spontaneous term labor. The increase in maternal estradiol preceded the increase in maternal oxytocin levels and myometrial contractions. The onset of the increase in maternal plasma oxytocin was closely associated with the appearance of myometrial contractions after delta4-androstenedione treatment. In contrast, no sustained premature contractions or changes in estradiol and oxytocin occurred in intralipid-treated monkeys.
We conclude that in the 0.8 gestation rhesus monkey (1) the increase in maternal plasma estradiol precedes the increase in maternal plasma oxytocin after delta4-androstenedione treatment and (2) delta4-androstenedione-induced preterm myometrial contractions are closely associated in time with physiologic increases in maternal plasma oxytocin concentrations.
我们的目的是研究在妊娠0.8期的恒河猴中,δ4-雄烯二酮诱导的子宫肌层活动模式从挛缩转变为收缩与母体血浆雌二醇和催产素浓度之间的时间关系。
八只恒河猴(妊娠132至136天)在氟烷麻醉下植入股动脉和静脉导管以及子宫肌电图电极。在妊娠138至142天,从黑暗开始前2小时起,每隔30分钟采集一次母体股动脉血样,用于测量雌二醇和催产素,共采集7小时。在基线采样后的第二天,对四只猴子开始持续静脉输注δ4-雄烯二酮(以0.25 ml·hr-1的速度在10%的中链脂肪酸甘油三酯中输注,剂量为0.3 mg·kg-1·hr-1),而另外四只猴子仅静脉输注中链脂肪酸甘油三酯。在开始输注δ4-雄烯二酮或中链脂肪酸甘油三酯后的第1天和第3天重复采样方案。计数宫缩情况,并通过放射免疫分析法测量雌二醇和催产素。
雄烯二酮促进了子宫肌层收缩的夜间过早增加,同时母体血浆雌二醇和催产素浓度也增加,其幅度与足月自然分娩时测得的相似。母体雌二醇的增加先于母体催产素水平和子宫肌层收缩的增加。母体血浆催产素增加的开始与δ4-雄烯二酮治疗后子宫肌层收缩的出现密切相关。相比之下,接受中链脂肪酸甘油三酯治疗的猴子未出现持续的过早宫缩或雌二醇和催产素的变化。
我们得出结论,在妊娠0.8期的恒河猴中,(1)δ4-雄烯二酮治疗后母体血浆雌二醇的增加先于母体血浆催产素的增加;(2)δ4-雄烯二酮诱导的早产子宫肌层收缩在时间上与母体血浆催产素浓度的生理性增加密切相关。